Life Science Investing Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform
Life Science Investing Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates
Life Science Investing Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit
Life Science Investing Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares
Resource Expansion Drilling Confirms 3,000 metres of New Uranium Trends with Best Drill Hole of 1.4 GT over 7.6 metres
